Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

DoseSpot, which delivers best-in-class e-prescribing, insurance verification and revenue cycle management solutions for healthcare providers, announced today the results of a new data analysis on 102, ...

The UK is studying cases of pancreatitis in people taking GLP-1 drugs for weight loss or type 2 diabetes to see if genetics may make them vulnerable.

Attorney General Dave Sunday is warning Pennsylvanians to make sure they're using licensed pharmacies for GLP-1 drugs amid a growing counterfeit market.

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

In a recent panel conversation, healthcare and industry experts discussed where to find reliable guidance in a sea of ...